注意缺陷多动障碍儿童与成人皮层下脑体积差异的横断面 mega 分析
该研究基于 ENIGMA 国际协作组 23 个站点、1713 例注意缺陷多动障碍(ADHD)患者与 1529 名对照的个体化 T1 加权 MRI 数据开展横断面 mega 分析。结果显示,ADHD 患者伏隔核、杏仁核、尾状核、海马、壳核及颅内体积较对照更小,而苍白球与丘脑无差异。探索性终生建模提示 ADHD 存在成熟延迟与退化延迟,成人病例对照差异不显著。
要点
- ADHD 患者伏隔核、杏仁核、尾状核、海马、壳核及颅内体积较对照小。
- 苍白球与丘脑体积在 ADHD 与对照间无差异。
- 探索性分析提示 ADHD 存在成熟延迟与退化延迟,成人差异不显著。
核心结论
- 与对照相比,ADHD 患者伏隔核、杏仁核、尾状核、海马、壳核及颅内体积更小,苍白球与丘脑无差异。
- 探索性终生建模提示 ADHD 存在成熟延迟与退化延迟,成人病例对照差异不显著。
研究设计与样本
- 横断面 mega 分析,数据来自 ENIGMA 国际协作组,冻结于 2015 年 2 月 8 日。
- 样本为 1713 例 ADHD 患者与 1529 名对照,来自 23 个站点,中位年龄 14 岁(范围 4–63 岁)。
- 各站点按统一方案分析结构 T1 加权 MRI 脑扫描,主要结局为皮层下结构与颅内体积的病例对照差异。
临床怎么用
- 结果提示 ADHD 涉及伏隔核、杏仁核、海马等皮层下结构体积减小,可支持对 ADHD 神经生物学基础的理解。
- 探索性终生建模提示 ADHD 存在成熟延迟与退化延迟,可为解释不同年龄阶段脑结构差异提供假设。
- 结果不支持精神兴奋剂药物使用影响脑体积,也不支持共病精神障碍或症状评分影响上述病例对照差异。
局限性
- 横断面设计无法确证终生脑表型轨迹,作者指出需有足够把握度的纵向研究验证。
- 探索性终生建模结果为假设生成性质,成人病例对照差异不显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neuroimaging studies have shown structural alterations in several brain regions in children and adults with attention deficit hyperactivity disorder (ADHD). Through the formation of the international ENIGMA ADHD Working Group, we aimed to address weaknesses of previous imaging studies and meta-analyses, namely inadequate sample size and methodological heterogeneity. We aimed to investigate whether there are structural differences in children and adults with ADHD compared with those without this diagnosis. METHODS: In this cross-sectional mega-analysis, we used the data from the international ENIGMA Working Group collaboration, which in the present analysis was frozen at Feb 8, 2015. Individual sites analysed structural T1-weighted MRI brain scans with harmonised protocols of individuals with ADHD compared with those who do not have this diagnosis. Our primary outcome was to assess case-control differences in subcortical structures and intracranial volume through pooling of all individual data from all cohorts in this collaboration. For this analysis, p values were significant at the false discovery rate corrected threshold of p=0·0156. FINDINGS: Our sample comprised 1713 participants with ADHD and 1529 controls from 23 sites with a median age of 14 years (range 4-63 years). The volumes of the accumbens (Cohen's d=-0·15), amygdala (d=-0·19), caudate (d=-0·11), hippocampus (d=-0·11), putamen (d=-0·14), and intracranial volume (d=-0·10) were smaller in individuals with ADHD compared with controls in the mega-analysis. There was no difference in volume size in the pallidum (p=0·95) and thalamus (p=0·39) between people with ADHD and controls. Exploratory lifespan modelling suggested a delay of maturation and a delay of degeneration, as effect sizes were highest in most subgroups of children (<15 years) versus adults (>21 years): in the accumbens (Cohen's d=-0·19 vs -0·10), amygdala (d=-0·18 vs -0·14), caudate (d=-0·13 vs -0·07), hippocampus (d=-0·12 vs -0·06), putamen (d=-0·18 vs -0·08), and intracranial volume (d=-0·14 vs 0·01). There was no difference between children and adults for the pallidum (p=0·79) or thalamus (p=0·89). Case-control differences in adults were non-significant (all p>0·03). Psychostimulant medication use (all p>0·15) or symptom scores (all p>0·02) did not influence results, nor did the presence of comorbid psychiatric disorders (all p>0·5). INTERPRETATION: With the largest dataset to date, we add new knowledge about bilateral amygdala, accumbens, and hippocampus reductions in ADHD. We extend the brain maturation delay theory for ADHD to include subcortical structures and refute medication effects on brain volume suggested by earlier meta-analyses. Lifespan analyses suggest that, in the absence of well powered longitudinal studies, the ENIGMA cross-sectional sample across six decades of ages provides a means to generate hypotheses about lifespan trajectories in brain phenotypes. FUNDING: National Institutes of Health.
引用
- Hoogman M, Bralten J, Hibar DP, et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry. 2017. PMID: 28219628. doi:10.1016/S2215-0366(17)30049-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。